Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

Sponsor
Rigshospitalet, Denmark
Study ID
NCT05840575
Status
Recruiting
Apply to this trial

Conditions

  • Cancer
  • Chemo-brain
  • Chemotherapeutic Toxicity
  • Chemotherapy-Related Cognitive Impairment
  • Childhood Cancer
  • Hodgkin Lymphoma
  • Leukemia
  • Non Hodgkin Lymphoma
  • Sarcoma
  • Testicular Cancer

Eligibility Criteria

Sex
ALL
Age
7 Years - 29 Years
Healthy Volunteers
Accepted

Study Details

The MyBrain study investigates the brain function of children, adolescents and young adults during and after chemo treatment for cancer. The tests include 1) cognitive skills such as memory and attention; 2) the brain's electrical activity; 3) and biological markers related to brain function. The aim of the study is to better understand the trajectories of cognitive functioning and measures that have been associated with cognitive impairment in patients treated with chemotherapy.

Key Dates

First listed
May 3, 2023
Start date
Mar 1, 2022
Status verified
Apr 2023
Primary completion
Mar 1, 2027
Completion
Mar 1, 2027

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Solid tumor patients
    Patients diagnosed with solid tumor cancers
  • Arm: Haematological patients
    Patients diagnosed with haematological cancers

Primary Outcome Measure

Performance on clinical neurocognitive tests: Wechlers scale [ Time Frame: T0: within 30 days of diagnosis ]

Central Contacts

Find similar trials

Nationwide
Leukemia (other) trialsOncology trialsBlood cancer trials

Related Studies